Healthcare Stocks Face a New Test in Congress
A shifting Congress could bring big changes to drug prices and healthcare stocks.

Washington is getting ready for a shakeup. Power is shifting on Capitol Hill, and investors are watching closely. Healthcare companies sit right in the crosshairs of this change.
A new group of leaders wants to lower drug costs. Lawmakers often target hospital fees and insurance rules when they take power. These plans can cut into company profits.
Because of this news, healthcare stocks might move slowly in the coming months. Fund managers often pause their buying when new laws hang in the balance. They prefer to wait until the rules become clear.
You can protect your money by staying patient. Watch how the new leaders vote before making big moves in your portfolio. Good companies tend to adapt over time.
Source: CNBC




